"What" Series
What is Duration of Clinical Benefit (DoCB) in Clinical Trials?
16 October 2023
2 min read
Duration of Clinical Benefit (DoCB) is defined as the time from randomization to disease progression or death in patients who achieve complete remission, partial remission, or disease stability for 24 weeks or longer. It is a primary endpoint used in clinical trials, where the main goal is to prolong survival with disease stability.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Keep Reading
Back to all blogs →
Latest Hotspot
3 min read
REGENXBIO Reveals Clinical Information from Phase I/II Study of RGX-202
16 October 2023
REGENXBIO Inc. disclosed further provisional safety information and preliminary effectiveness results from the phase I/II AFFINITY DUCHENNE™ study of RGX-202 aimed at treating Duchenne Muscular Dystrophy.
Latest Hotspot
3 min read
FDA approves Transcenta Phase III Study of Osemitamab for Gastric/Gastroesophageal Cancer
16 October 2023
Transcenta Holding Limited states that it has received the green light from FDA to continue with TranStar 301,This trial is conducted for Osemitamab (TST001) used together with Nivolumab and chemotherapy.
"What" Series
2 min read
What is Time to next treatment (TTNT) in Clinical Trials?
16 October 2023
Time to Next Treatment (TTNT) is defined as the period from the start of the treatment to the start of the next line of treatment.
Bio Sequence
2 min read
Precision Enhancements and More Awaits You in Our Latest Bio Update!
16 October 2023
The October release of the Patsnap Bio Sequence Database provides a plethora of enhancements in order to improve your searching experience and elevate the efficiency of your FTO review.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.